Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice
[en] The present study aimed to test the hypothesis that mice lacking the MCHR1 receptor (Melanin-Concentrating Hormone Receptor-1) present
an elevated vulnerability towards the neurobehavioural effects of D-amphetamine, presumably due to previously established up-regulations of
dopamine D1 receptors in these mice. We examined the psychomotor effects of five once-daily injections of 1.5 and 3 mg/kg D-amphetamine (i.p.)
or ten once-daily injections of 2.25 mg/kg D-amphetamine in knockout (KO) mice lacking the MCHR1 receptor. The first injection of Damphetamine
induced a greater psychomotor response amongst the KO mice at 2.25 and 3.0 mg/kg. On all subsequent D-amphetamine injections,
KO mice still showed greater levels of psychomotor activity than the WT mice, but with no between-genotype difference in the rate of
development of sensitization (similar slopes of the curves). Furthermore, 24 h after the last injection of 2.25 mg/kg D-amphetamine both genotypes
exhibited a significant post-sensitization conditioned activity. Thus, MCHR1 receptors are likely not deeply involved in the mechanisms of
induction of sensitization and related conditioned activity induced by D-amphetamine, albeit our results confirm a contribution of these receptors
to the mechanisms of the acute effects of that drug, possibly via an inhibitory action on the dopaminergic mesolimbic system. Our results do not
support the hypothesis of a functional contribution of MCHR1 receptors to the addictive effects of D-amphetamine
Research Center/Unit :
Centre de Neurosciences Cognitives et Comportementales - ULiège
Disciplines :
Neurosciences & behavior
Author, co-author :
Tyhon, Amélie ✱; Université de Liège - ULiège > Département des sciences cognitives > Neuroscience comportementale et psychopharmacologie expér.
Lakaye, Bernard ✱; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Grisar, Thierry ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Tirelli, Ezio ; Université de Liège - ULiège > Département des sciences cognitives > Neuroscience comportementale et psychopharmacologie expér.
✱ These authors have contributed equally to this work.
Language :
English
Title :
Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice
Adamantidis A., Thomas E., Tyhon A., Seutin V., Tirelli E., and Grisar T. Disrupting the melanin-concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function. Eur J Neurosci 21 (2005) 2837-2844
Ahmed S.H., Oberling P., Di Scala G., and Sandner G. Amphetamine-induced conditioned activity does not result from a failure of rats to habituate to novelty. Psychopharmacology 123 (1996) 325-332
Astrand A., Bohlooly M., Larsdotter S., Mahlapuu M., Andersen H., Tornell J., et al. Mice lacking melanin-concentrating hormone receptor-1 demonstrate increased heart rat associated with altered autonomic activity. Am J Physiol, Regul Integr Comp Physiol 287 (2004) R749-R758
Aujla H., and Beninger R.J. Intra-BLA or intra-NAC infusions of the dopamine D3 receptor partial agonist, BP897, block intra-NAC amphetamine conditioned activity. Behav Neurosci 118 (2004) 1324-1330
Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319 (1992) 218-245
Cabib S. Strain-dependent behavioural sensitization to amphetamine: role of environmental influences. Behav Pharmacol 4 (1993) 367-374
Chaudry I.A., Turkanis S.A., and Karler R. Characteristics of reverse tolerance to amphetamine-induced locomotor stimulation in mice. Neuropharmacology 27 (1987) 777-785
Corvol J.C., Valjent E., Pascoli V., Robin A., Stipanovich A., Luedtke R.R., et al. Quantitative changes in G alpha olf protein levels, but not D1 receptors, after specifically acute response to psychostmulants. Neuropsychopharmacology 32 (2007) 1109-1121
Cunnigham C.L. Pavlovian drug conditioning. In: van Haaren F. (Ed). Methods in behavioural pharmacology (1993), Elsevier, Amsterdam 349-381
Damianopoulos E.N., and Carey R.J. Pavlovian conditioning of CNS drug effects: a critical review and new experimental designs. Rev Neurosci 3 (1992) 65-77
Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137 (2002) 75-114
Di Leone J.R., Georgescu D., and Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci 73 (2003) 759-768
Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolanos C.A., Marsh D.J., et al. The hypothamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behaviour and forced-swim performance. J Neurosci 25 (2005) 2933-2940
Gould T.D., O'Donnell K.C., Picchini A.M., and Manji H.K. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32 (2007) 1321-1333
Hayashi T., Ohashi K., and Tadokoro S. Conditioned drug effects to d-amphetamine- and morphine-induced motor acceleration in mice: experiential approach for placebo effect. Jpn J Pharmacol 30 (1980) 93-100
Juhila J., Honkanen A., Sallinen J., Haapalinna A., Korpi E.R., and Schenin M. Alpha(2A)-adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice. Eur J Pharmacol 517 (2005) 74-83
Keppel G., and Wickens T.D. Design and analysis: a researcher's handbook. Fourth edition (2004), Pearson Education, Upper Saddle River, N.J.
Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., and Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23 (2003) 7-11
Kuribara H. Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice. Eur J Pharmacol 316 (1996) 1-5
Lalonde R., and Qian S. Exploratory activity, motor coordination, and spatial learning in Mchr1 knockout mice. Behav Brain Res 178 (2007) 293-304
McDougall S.A., Reichel C.M., Cyr M.C., Karper P.E., Nazarian A., and Crawford C.A. Importance of D1 receptors for associative components of amphetamine-induced behavioral sensitization and conditioned activity: a study using D1 receptor knockout mice. Psychopharmacology 183 (2005) 20-30
MacKerchar T.L., Zarcone T.J., and Fowler S.C. Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129X1/SvJ, C3H/HeJ, and CD-1 mice. J Neurosci Methods 153 (2006) 48-54
Marsh D.J., Weingarth D.T., Novi D.E., Chen H.Y., Trumbauer M.E., Chen A.S., et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A 99 (2002) 3240-3245
Martin-Iverson M.T., and McManus D.J. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning. Brain Res 521 (1990) 175-184
Mazurski E.J., and Beninger R.J. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion. Psychopharmacology 105 (1991) 107-112
Mead A.N., and Stephens D.N. AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitization, but not in the expression of amphetamine-induced conditioned activity in mice. Neuropharmacology 37 (1998) 1131-1138
Miner L.L. Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol Biochem Behav 58 (1997) 25-30
Ralph R.J., Paulus M.P., and Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther 298 (2001) 148-2001
Robinson T.E., and Berridge K.C. Addiction. Ann Rev Psychol 54 (2003) 25-53
Roy M., David N.K., Danao J.V., Baribault H., Tian H., and Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype-1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 31 (2006) 112-120
Saito Y., Cheng M., Leslie F.M., and Civelli O. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 435 (2001) 26-40
Sanchez M.S., Barontini M., Armando I., and Celis M.E. Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine in the rat ventral tegmental area. Cell Mol Neurobiol 21 (2001) 523-533
Saper C.B., Chou T.C., and Elmquist J.K. The need to feed: homeostatic and hedonic control of eating. Neuron 36 (2002) 199-211
Segal D.S., and Kuczenski R. Behavioral pharmacology of amphetamine. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its analogs: psychopharmacology, toxicology, and abuse (1994), Academic Press, San Diego 115-150
Sellings L.H.L., and Clarke P.B.S. 6-hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity. Synapse 59 (2006) 374-377
Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor deficient mice. J Neurosci 25 (2005) 914-922
Steckler T., and Holsboer F. Conditioned activity to amphetamine in transgenic mice expressing an antisense RNA against the glucocorticoid receptor. Behav Neurosci 115 (2001) 207-219
Tirelli C., and Heidbreder C. Conditioning of and contextual sensitization to apomorphine-induced climbing in mice: evidence against the habituation hypothesis. Behav Neurosci 113 (1999) 368-376
Tirelli E., and Terry P. Amphetamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes. Behav Pharmacol 9 (1998) 409-419
Tyhon A., Amantidis A., Foidart A., Grisar T., Lakaye B., and Tirelli E. Mice lacking the melanin-concentrating hormone receptor-1 exhibit an atypical psychomotor susceptibility to cocaine and no conditioned cocaine response. Behav Brain Res 173 (2006) 94-103
Ujike H., Akiyama K., and Otsuki S. D2 nut not D1 dopamine agonists produce augmented behavioral response in rats after sub-chronic treatment with methamphetamine or cocaine. Psychopharmacology 102 (1990) 459-464
Vanderschuren L.J.M.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 (2000) 99-120
Vandershuren L.J., Schoffenlmeer A.N., Mulder A.H., and De Vries T.J. Dopaminergic mechanisms mediating the long term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology 143 (1999) 244-253
Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization to amphetamine in the ventral tegmental area. J Neurosci 16 (1996) 2411-2420
Walters C.L., and Blendy J.A. Different requirements for CAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21 (2001) 9438-9444
Xu M., Guo Y., Vorhees C.V., and Zang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res 852 (2000) 198-207
Xu Y.L., Jackson V.R., and Civelli O. Orphan G protein-coupled receptors and obesity. Eur J Pharmacol 500 (2004) 243-253
Zhou D., Shen Z., Strack A.M., Marsh D.J., and Shearman L.P. Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice. Regul Pept 124 (2005) 53-63
